Keep Factually independent
Whether you agree or disagree with our analysis, these conversations matter for democracy. We don't take money from political groups - even a $5 donation helps us keep it that way.
What is Neurocept's CEO or company response to Sanjay Gupta's CNN comments?
Executive Summary
Neurocept has no documented, verifiable public statement or CEO response to Sanjay Gupta’s comments on CNN in the materials provided; available consumer complaints and media items instead document allegations that the company’s marketing used AI-generated images and videos falsely implicating Dr. Gupta, and Dr. Gupta has publicly denounced the use of his likeness in deepfake ads [1] [2]. The record in these sources is fragmented: Trustpilot reviewers report alleged scams and misuse of celebrity images, while CNN coverage centers on Gupta’s own reporting and his denouncement of deepfakes rather than on any Neurocept reply [1] [3] [2].
1. Consumer Allegations Paint a Picture of Deceptive Marketing — What reviewers say and why it matters
Multiple Trustpilot reviewers claim Neurocept misrepresents product ingredients, delivers poor customer service, and uses AI-generated celebrity images and videos—explicitly naming Dr. Sanjay Gupta as one of the likenesses used without consent [1]. These reviews assert patterns of deceptive marketing and refund difficulties, which, if accurate, elevate the issue beyond isolated complaints into a reputational and potential legal problem. Trustpilot entries are dated November 2, 2025 in the analysis record [1], indicating recent consumer dissatisfaction. However, Trustpilot complaints are user-generated content and can reflect both genuine grievances and coordinated campaigns; the presence of multiple similar claims increases credibility but does not substitute for company confirmation or regulatory findings.
2. Sanjay Gupta’s Media Role Is Documented — But the CNN pieces don’t focus on Neurocept
The CNN pieces included in the materials concentrate on Dr. Gupta’s medical reporting, his personal preventive neurology coverage, and his explicit rejection of deepfake ads that misuse his likeness [3] [2]. One CNN article details Gupta’s cognitive testing and brain-health reporting without referencing Neurocept, showing no direct nexus in those stories between his CNN commentary and Neurocept [3]. Separately, CNN and related items show Gupta publicly denouncing AI-driven fake ads using his image, which aligns with reviewer claims that celebrity deepfakes were used to market health products; however, the provided CNN pieces stop short of naming Neurocept as the source of those deepfakes [2].
3. Absence of a Corporate Response Is the Central Finding — What’s missing from the record
Across the supplied sources there is no identified statement from Neurocept’s CEO or official company communications addressing Gupta’s comments or the deepfake allegations [1] [3] [4]. The Trustpilot analysis notes reviewers’ observation of no corporate reply; the CNN materials likewise do not record any Neurocept response [1] [3]. This absence matters: in disputes involving alleged consumer harm and unauthorized use of public figures, companies often issue denials, takedown promises, or corrective actions. The lack of such visible action in these documents leaves the claims unresolved in the public record provided here.
4. Conflicting Sources and Limitations — What can and cannot be concluded from the dataset
The dataset mixes user reviews, news features about Gupta’s clinical reporting, and commentary about deepfake misuse of his likeness [1] [3] [2]. This creates a plausible linkage between deepfake misuse and Neurocept only by inference: reviewers allege the company used fake celebrity endorsements, and Gupta denounced deepfakes, but no source in this set directly records Neurocept admitting, denying, or explaining the alleged use of Dr. Gupta’s image [1] [2]. Absence of corroborating corporate statements, regulatory actions, or independent forensic analysis prevents definitive attribution. The dataset also includes older background items on Gupta’s past reporting errors and general media roles which do not bear on current allegations [5].
5. Practical next steps and what further reporting would resolve the gap
To close the evidentiary gap, independent verification is required: archived Neurocept web pages showing the alleged ads, DMCA or takedown notices, a direct company statement or CEO comment, or reporting from consumer-protection authorities would be decisive. Given the claims of unauthorized use of a public figure and possible mislabeled ingredients, regulators or platforms (advertising networks, payment processors) could have records; checking those sources after November 8, 2025 would be necessary. For now, the balanced conclusion from the provided materials is that consumer complaints and Gupta’s denouncements establish a credible concern about deepfake-promoted health products, while no documented Neurocept response or CEO statement appears in the supplied record [1] [2].